Image

Physical Activity and Sedentary Behavior During Pregnancy

Physical Activity and Sedentary Behavior During Pregnancy

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

Our main objective is to evaluate the intervention that best enables women's adherence to physical activity (PA).

Our hypothesis is that identifying types of interventions suitable for pregnant women (in-person PA sessions, videoconferences or mixed format) could help improve their PA level and simultaneously reduce their sedentary behavior (SB).

Description

PA has beneficial effects on physical, psychological, and social health, and its regular practice helps to prevent numerous chronic diseases. During pregnancy, PA also has many benefits for women's physical condition, weight gain, gestational hypertension, lower back and pelvic pain, and postpartum depressive symptoms and may also reduce fetal macrosomia and positively affect neurogenesis, language development, memory, and other learning-associated cognitive functions. (CNSF 2021). PA is thus recommended to all pregnant women for 150 to 180 minutes a week, adapted to their health status, physical condition, and course of pregnancy. It is also recommended that women limit their Sedentary Behaviour (SB) (to ≤7 waking h/day) during pregnancy.

No French study has assessed the impact of a PA program during pregnancy, and no published study has proposed videoconference PA sessions during pregnancy. Pregnant women's adherence to PA is a limiting factor found in many interventional studies. Possible changes in maternal behavior in practicing PA and reducing SB during pregnancy could also favorably affect the health of mother and child and thus subsequent PA. Given PA's many benefits and SB's harmful effects during pregnancy, assessing programs that enable pregnant women to both increase PA levels and reduce SB seems pertinent and valuable.

Eligibility

Inclusion Criteria:

  • Pregnant women of more of 18 years and who are being monitored for pregnancy in the Clermont-Ferrand metropolitan area,
  • Planned to give birth in a maternity unit localized in Clermont-Ferrand metropolitan area (CHU Estaing or Clinique de la Chataigneraie),
  • Agreeing to be randomized, to follow the physical activity program offered in the Clermont-Ferrand metropolitan area, and to follow up as part of the study,
  • Able to give informed consent to participate in the research,
  • Affiliated to a social security scheme
  • And between 14+0d and 21+6d weeks of gestation.

Non inclusion Criteria:

  • Women under guardianship, curators, deprived of liberty or under court protection,
  • With a history of recurrent miscarriage,
  • Presenting a multiple pregnancy,
  • Hemoglobinemia <9g/dL or symptomatic anemia,
  • Presenting eating disorders or a BMI ≤ 18.5 or a BMI ≥ 40,
  • With orthopedic limitations,
  • Presenting cardiovascular or pulmonary disease,
  • Uncontrolled thyroid disease,
  • Presenting a high level of smoking,
  • With significant health problems,
  • Premature rupture of membranes,
  • Premature labor during this pregnancy or a history of at least 2 premature births,
  • Persistent vaginal bleeding,
  • Cervical incompetence,
  • Evidence of intrauterine growth restriction,
  • Uncontrolled epilepsy,
  • Diabetes (previous or gestational, diagnosed in the 1st trimester) or chronic hypertension,
  • Or having a planned home birth.

Study details
    Pregnant Woman

NCT06585085

University Hospital, Clermont-Ferrand

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.